Erin Kathleen Mahoney Briones, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: Charlestown Healthcare Center, 73 High Street, Charlestown, MA 02139 Phone: 617-724-8135 Fax: 617-724-9334 |
Katherine Altshul Darci, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 17 Mount Vernon St, Unit B, Charlestown, MA 02129 Phone: 617-306-0419 |
Dr. Mia M Maccollin, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 149 13th St, 6th Floor Cyn 149 6, Charlestown, MA 02129 Phone: 617-726-7856 Fax: 617-724-9620 |
Dr. Nicholas Pepe, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 73 High St, Charlestown Healthcare Center, Charlestown, MA 02129 Phone: 617-724-8135 Fax: 617-724-9334 |
Dr. Mariette Murphy, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 73 High St, Charlestown Healthcare Center, Charlestown, MA 02129 Phone: 617-724-8135 Fax: 617-724-9334 |
News Archive
Investigators have identified a new mechanism that controls the number of hematopoietic stem cells - cells that give rise to all blood and immune system cells. In a report in the online Early Edition of Proceedings of the National Academy of Sciences, researchers from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute identify a tiny RNA molecule that increases the number of these blood stem cells, an advance that may improve treatment of blood system cancers.
Women experiencing signs of breast cancer vary in how they value, use, and trust 'Dr Google' when making sense of their symptoms, a new study in the journal Health, Risk & Society reports.
Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy, according to a study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). In the western world, deaths from ectopic pregnancy are not common but in the developing world one in ten women who are admitted with an ectopic pregnancy die.
Waters Corporation reported fourth quarter 2009 sales of $429 million, an increase of 3% from sales of $418 million in the fourth quarter of 2008. In the quarter, foreign currency translation increased sales growth rate by 4% and on a currency neutral basis, sales decreased by 1% in comparison to the prior year's fourth quarter sales. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.08, compared to $1.01 for the fourth quarter of 2008. On a non-GAAP basis, including the adjustments in the attached reconciliation, E.P.S. grew 5% to $1.12 from $1.07 in the fourth quarter of 2008.
Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.
› Verified 7 days ago